Verrica Pharmaceuticals Inc.
VRCA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$76,579 | -$66,995 | -$24,487 | -$35,080 |
| Dep. & Amort. | $1,269 | $836 | $718 | $472 |
| Deferred Tax | $0 | $0 | $0 | $66 |
| Stock-Based Comp. | $7,164 | $14,376 | $4,985 | $6,053 |
| Change in WC | $2,027 | $9,859 | -$1,800 | -$535 |
| Other Non-Cash | $5,192 | $3,347 | $1,934 | $1,442 |
| Operating Cash Flow | -$60,927 | -$38,577 | -$18,650 | -$27,582 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$27 | -$362 | -$302 | -$883 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$4,485 | -$68,914 |
| Inv. Sales/Matur. | $0 | $0 | $59,008 | $69,000 |
| Other Inv. Act. | $8 | $0 | -$180 | -$201 |
| Investing Cash Flow | -$19 | -$362 | $54,041 | -$998 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,064 | $44,082 | -$43,754 | $4,970 |
| Stock Issued | $39,637 | $30,300 | $26,901 | $28,118 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $155 | -$169 | -$17 | $558 |
| Financing Cash Flow | $37,728 | $74,213 | -$16,870 | $33,646 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$23,218 | $35,274 | $18,521 | $5,066 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $69,547 | $34,273 | $15,752 | $10,686 |
| End Cash | $46,329 | $69,547 | $34,273 | $15,752 |
| Free Cash Flow | -$60,954 | -$38,939 | -$18,952 | -$28,465 |